Leukocyte adhesion deficiency type 1 with normal expression of CD 11a, CD11b and CD11c
DOI:
https://doi.org/10.55629/pakjpathol.v35i2.817Abstract
Leukocyte Adhesion Deficiency Type I (LAD-I) is a rare autosomal recessive disorder resulting from ITGB2 gene mutations on long arm of chromosome 21. This mutation disrupts leukocyte migration, causing impaired wound healing, recurrent infections, periodontitis, delayed umbilical cord separation and neutrophilic leukocytosis. Diagnosis involves flow cytometry to assess CD18, CD11a, CD11b, and CD11c surface expression, along with gene mutation analysis. Early detection and management are crucial for those with LAD-I. Here, we present a case of 11 years old male child with recurrent skin infections and diagnosed with rare phenotype of LAD-1 with normal expression of CD11a, CD11b and CD11c. This case improved our understanding of the mild and delayed presentation of Leukocyte Adhesion Deficiency Type 1 (LAD-I) with variable CD marker expression. It highlights the value of using flow cytometry methods to diagnose inborn errors of immunity, highlighting the need for continued study and increased awareness in this area. Increased knowledge of the various phenotypic expressions of LAD-I among medical professionals and researchers could facilitate prompt diagnosis and treatment, ultimately leading to better outcome and improved quality of life in patients.
Keywords: Adhesion molecules, Flow-cytometric analysis, Integrins, Leukocyte adhesion deficiency, Molecular analysis
References
Novoa EA, Kasbekar S, Thrasher AJ, Kohn DB, Sevilla J, Nguyen T, et al. Leukocyte adhesion deficiency-I: A comprehensive review of all published cases. J Allergy Clin Immuno Pract. 2018; 6(4): 1418-20.
DOI: https://doi.org/10.1016/j.jaip.2017.12.008
van de Vijver E, van den Berg TK, Kuijpers TW. Leukocyte adhesion deficiencies. Hematol Clin. 2013; 27(1): 101–16.
Geroldinger-Simić M, Lehner K, Klein G, Sepp N, Jabkowski J. An adult with severe leukocyte adhesion deficiency type 1. JAAD Case Rep. 2022; 19: 1-3.
DOI: https://doi.org/10.1016%2Fj.jdcr.2021.10.031
Das J, Sharma A, Jindal A, Aggarwal V, Rawat A. Leukocyte adhesion defect: Where do we stand circa 2019? Genes Dis. 2020; 7(1): 107-14.
DOI: https://doi.org/10.1016/j.gendis.2019.07.012
Vandendriessche S, Cambier S, Proost P, Marques PE. Complement receptors and their role in leukocyte recruitment and phagocytosis. Front Cell Dev Biol. 2021; 9: 624025.
DOI: https://doi.org/10.3389/fcell.2021.624025
Bashir MM, Hussain M, Ahmad D, Tipu HN. Leukocyte adhesion deficiency type 1 with low expression of cd 11b. J Coll Physicians Surg Pak. 2018; 28(6): S87-s8.
DOI: https://doi.org/10.29271/jcpsp.2018.06.s87
Kambli PM, Bargir UA, Yadav RM, Gupta MR, Dalvi AD, Hule G, et al. Clinical and genetic spectrum of a large cohort of patients with leukocyte adhesion deficiency type 1 and 3: a multicentric study from India. Front Immunol. 2020; 11: 612703.
DOI: https://doi.org/10.3389/fimmu.2020.612703
Wolach B, Gavrieli R, Wolach O, Stauber T, Abuzaitoun O, Kuperman A, et al. Leucocyte adhesion deficiency* - A multicentre national experience. Eur J Clin Invest. 2019; 49(2): e13047. DOI: https://doi.org/10.1111/eci.13047
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Muhammad Hussain, Mustajab Alam, Muhammad Zain Arshad, Aftab Hassan, Maryam Bibi, Hina Mushtaq
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.